These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16117150)

  • 1. [Betaserk in the treatment of aftereffects of craniocerebral injury and vascular events].
    Odinak MM; Kovalenko AP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(7):55-7. PubMed ID: 16117150
    [No Abstract]   [Full Text] [Related]  

  • 2. [Betaserc and improvement of life quality in war veterans].
    Larikova TI; Cherevikova GM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(3):68-70. PubMed ID: 15822746
    [No Abstract]   [Full Text] [Related]  

  • 3. [Betaserk efficiency in cochlear and vestibular disorders in the regional surdocenter].
    Pekaskiĭ SI
    Vestn Otorinolaringol; 2001; (3):61. PubMed ID: 11510053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vertigo: patient management tactics].
    Vasyl'chuk IS; Kozlova OO; Trinus KF; Holovchenko IuI; Slobodin TM
    Lik Sprava; 2012; (7):84-7. PubMed ID: 23350121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo.
    Albera R; Ciuffolotti R; Di Cicco M; De Benedittis G; Grazioli I; Melzi G; Mira E; Pallestrini E; Passali D; Serra A; Vicini C
    Acta Otolaryngol; 2003 Jun; 123(5):588-93. PubMed ID: 12875580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A use of betaserc in ataxic syndromes].
    Prokopenko SV; Rudnev VA; Afanas'eva EV; Abramov VG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):41-5. PubMed ID: 15554141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of vertigo with betaserk in patients with vascular and traumatic cerebral injuries].
    Gusev EI; Nikonov AA; Skvortsova VI; Avakian GN; Gordeeva TN; Katunina EA; Ataian AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(11):19-21. PubMed ID: 9845935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of betaserk in combined treatment of neurosensory hypoacusis and vestibulopathy in childhood].
    Chistiakova VR
    Vestn Otorinolaringol; 2004; (2):9-12. PubMed ID: 15111941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology, clinical features and betaserc therapy of vertigo in initial and reversible cerebrovascular pathology].
    Gornostaeva GV; Varakin IuIa; Prokopovich ME; Alekseeva NS; Fedin PA; Chechetkin AO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(9):14-7. PubMed ID: 16250576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of betaserk in experimental motor disease].
    Mantsev EI; Sigaleva EE
    Vestn Otorinolaringol; 2005; (6):49-52. PubMed ID: 16353011
    [No Abstract]   [Full Text] [Related]  

  • 11. [Betaserk in therapy of cochleovestibular disordes].
    Khrapko NS; Sedykh MI; As'kova LN; Tarasova NV; Velikanov AK; Baryshevskaia LA
    Vestn Otorinolaringol; 2006; (4):59-60. PubMed ID: 17152479
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of betaserk in patients with cochlear-vestibular disorders].
    Kadymov MI; Poliakova TS; Vladimirova TN
    Vestn Otorinolaringol; 1998; (5):49-50. PubMed ID: 9793432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Betaserc treatment of acute disorders of cerebral circulation with vestibulo-ataxic and cochleo-vestibular syndromes].
    Berdichevskiĭ MIa; Karmirian SA; Geĭko II; Miroshnichenko VE; Parkhaeva TN; Popova VG; Timchenko LV; Filina TV; Aristova LA
    Vestn Otorinolaringol; 2002; (4):32-3. PubMed ID: 12400131
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effects of betahistine on the function of equilibrium system].
    Kubiczkowa J
    Otolaryngol Pol; 1997; 51 Suppl 25():230-9. PubMed ID: 9757700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparable efficacy and tolerability between twice daily and three times daily betahistine for Ménière's disease.
    Ganança MM; Caovilla HH; Ganança FF
    Acta Otolaryngol; 2009 May; 129(5):487-92. PubMed ID: 18615332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does betahistine treatment have additional benefits to vestibular rehabilitation?
    Karapolat H; Celebisoy N; Kirazli Y; Bilgen C; Eyigor S; Gode S; Akyuz A; Kirazli T
    Eur Arch Otorhinolaryngol; 2010 Aug; 267(8):1207-12. PubMed ID: 20567979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Menière's disease. Current status].
    Darrouzet V; Bouccara D; Bozorg Grayeli A; Couloigner V; Negrevergne M; Sterkers O
    Rev Laryngol Otol Rhinol (Bord); 2001; 122(3):209-15. PubMed ID: 11799866
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of ibudilast on the reciprocal inhibitory visual-vestibular interaction closely related to dizziness after cerebral ischemia.
    Inoue N; Fukuda S; Inada T; Sameshima E; Tokushima Y; Harada M
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):51-5. PubMed ID: 23085301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of Betaserc in auditory and vestibular disturbances.
    Petrova D; Sachansca T; Datcov E
    Int Tinnitus J; 2004; 10(2):177-82. PubMed ID: 15732519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cerebral hemodynamics and statokinetic functions in patients with vertebral basilar vascular insufficiency].
    Butko DIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(12):38-42. PubMed ID: 15847325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.